{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T05:15:33Z","timestamp":1783055733763,"version":"3.54.6"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82505042"],"award-info":[{"award-number":["82505042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2025QC819"],"award-info":[{"award-number":["ZR2025QC819"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.critrevonc.2026.105385","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T16:24:22Z","timestamp":1779380662000},"page":"105385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bidirectional roles of senescence in tumor-infiltrating immune cells: Mechanisms, impact on immunotherapy, and therapeutic strategies"],"prefix":"10.1016","volume":"224","author":[{"given":"Ruohan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyu","family":"Zong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maowei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2026.105385_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/acel.70055","article-title":"\"Harnessing immune rejuvenation: advances in overcoming t cell senescence and exhaustion in cancer immunotherapy","volume":"24","author":"Admasu","year":"2025","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/23808993.2023.2292988","article-title":"\"The future of precision medicine in oncology","volume":"8","author":"Al Meslamani","year":"2023","journal-title":"Expert Rev. Precis. Med. Drug Dev."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105385_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123802","article-title":"\"Characteristics of the tumor microenvironment that influence immune cell functions: hypoxia, oxidative stress, metabolic alterations","volume":"12","author":"Augustin","year":"2020","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006002","article-title":"\"TIPE2 deletion improves the therapeutic potential of adoptively transferred NK cells","volume":"11","author":"Bi","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105385_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061017","article-title":"\"Aging of the immune system: focus on natural killer cells phenotype and functions","volume":"11","author":"Brauning","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12675","article-title":"\"Human CD8(+) EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK","volume":"17","author":"Callender","year":"2018","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13067","article-title":"\"Mitochondrial mass governs the extent of human T cell senescence","volume":"19","author":"Callender","year":"2020","journal-title":"Aging Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105385_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-006195","article-title":"\"Geospatial characterization of immune cell distributions and dynamics across the microenvironment in clear cell renal cell carcinoma","volume":"11","author":"Chakiryan","year":"2023","journal-title":"J. Immunother. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105385_bib9","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"\"Tumor-associated macrophages in liver cancer: From mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun."},{"issue":"Pt 3","key":"10.1016\/j.critrevonc.2026.105385_bib10","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.semcancer.2022.02.005","article-title":"\"Senescence and the tumor-immune landscape: implications for cancer immunotherapy","volume":"86","author":"Chibaya","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-025-01754-7","article-title":"\"Tertiary lymphoid structures in cancer: spatiotemporal heterogeneity, immune orchestration, and translational opportunities","volume":"18","author":"Deng","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib12","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/onco.13610","article-title":"\"Challenges and opportunities in the management of diffuse large B-cell lymphoma in older patients","volume":"26","author":"Di","year":"2021","journal-title":"Oncologist"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105385_bib13","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1158\/1078-0432.CCR-16-2981","article-title":"\"Successful transfer of umbilical cord blood CD34(+) hematopoietic stem and progenitor-derived NK cells in older acute myeloid leukemia patients.\"","volume":"23","author":"Dolstra","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2026.105385_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107198","article-title":"\"Macrophages and tumor-associated macrophages in the senescent microenvironment: from immunosuppressive TME to targeted tumor therapy","volume":"204","author":"Du","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105385_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41568-019-0156-2","article-title":"\"Unmasking senescence: context-dependent effects of SASP in cancer","volume":"19","author":"Faget","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105385_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001536","article-title":"\"Tumor-derived ILT4 induces T cell senescence and suppresses tumor immunity","volume":"9","author":"Gao","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105385_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1565278","article-title":"\"Senescence, NK cells, and cancer: navigating the crossroads of aging and disease","volume":"16","author":"Gergues","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105385_bib18","article-title":"\"Reversing immune aging to improve immunotherapy outcomes","volume":"16","author":"Gruber","year":"2026","journal-title":"Cancer Discov."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020210","article-title":"\"The functional crosstalk between myeloid-derived suppressor cells and regulatory t cells within the immunosuppressive tumor microenvironment","volume":"13","author":"Haist","year":"2021","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105385_bib20","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ccell.2023.05.004","article-title":"\"Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer","volume":"41","author":"Haston","year":"2023","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"\"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12929-022-00879-y","article-title":"\"Spatial multi-omics analyses of the tumor immune microenvironment","volume":"29","author":"Hsieh","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105385_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112810","article-title":"\"The evolving role of CD8(+)CD28(-) immunosenescent T cells in cancer immunology.\"","volume":"20","author":"Huff","year":"2019","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib24","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1038\/s41467-019-09882-8","article-title":"\"miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8(+) T cell fate.\"","volume":"10","author":"Ji","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105385_bib25","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1111\/cas.15824","article-title":"\"Senescent CD8(+) T cells acquire NK cell-like innate functions to promote antitumor immunity","volume":"114","author":"Kakuda","year":"2023","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib26","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1038\/s41467-025-58512-z","article-title":"\"Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors","volume":"16","author":"Kao","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13045-018-0629-x","article-title":"\"T cell senescence and CAR-T cell exhaustion in hematological malignancies","volume":"11","author":"Kasakovski","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105385_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104275","article-title":"\"Updated review on analysis of long non-coding RNAs as emerging diagnostic and therapeutic targets in prostate cancers","volume":"196","author":"Ke","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105385_bib29","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1080\/1061186X.2025.2525372","article-title":"\"Sacituzumab govitecan in HER2-negative breast cancer: redefining treatment paradigms","volume":"33","author":"Khadela","year":"2025","journal-title":"J. Drug Target"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12032-022-01922-6","article-title":"\"Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects","volume":"40","author":"Khadela","year":"2022","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib31","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2026019","article-title":"\"Spatial immune heterogeneity of hypoxia-induced exhausted features in high-grade glioma","volume":"11","author":"Kim","year":"2022","journal-title":"Oncoimmunology"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105385_bib32","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179298","article-title":"\"Deregulated expression of immune checkpoints on circulating CD4 T cells may complicate clinical outcome and response to treatment with checkpoint inhibitors in multiple myeloma patients","volume":"22","author":"Kulikowska de Na\u0142\u0119cz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105385_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065730","article-title":"\"Inappropriate expression of PD-1 and CTLA-4 checkpoints in myeloma patients is more pronounced at diagnosis: implications for time to progression and response to therapeutic checkpoint inhibitors","volume":"24","author":"Kulikowska de Na\u0142\u0119cz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105385_bib34","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ni.2981","article-title":"\"The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells","volume":"15","author":"Lanna","year":"2014","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105385_bib35","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1474-9726.2010.00584.x","article-title":"\"Human NK cells display major phenotypic and functional changes over the life span","volume":"9","author":"Le Garff-Tavernier","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/j.critrevonc.2026.105385_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108640","article-title":"\"Therapeutic targeting of DNA methylation alterations in cancer","volume":"258","author":"Lee","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib37","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"\"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105385_bib38","article-title":"\"CAR-NK cells for cancer immunotherapy: recent advances and future directions","volume":"15","author":"Li","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"\"Immunosenescence: a key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105385_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1255443","article-title":"\"The crosstalk of CD8+ T cells and ferroptosis in cancer","volume":"14","author":"Lin","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2017.226","article-title":"\"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity","volume":"32","author":"Liu","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-025-01735-w","article-title":"\"Immunosenescence and cancer: molecular hallmarks, tumor microenvironment remodeling, and age-specific immunotherapy challenges","volume":"18","author":"Liu","year":"2025","journal-title":"J. Hematol. Oncol."},{"issue":"587","key":"10.1016\/j.critrevonc.2026.105385_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6314","article-title":"\"Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib44","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41467-017-02689-5","article-title":"\"Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition","volume":"9","author":"Liu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105385_bib45","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jare.2024.12.043","article-title":"\"Targeting macrophages in cancer immunotherapy: frontiers and challenges","volume":"76","author":"Liu","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.critrevonc.2026.105385_bib46","article-title":"\"Immunotherapy: reshape the tumor immune microenvironment","volume":"13","author":"Lv","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13046-022-02433-y","article-title":"\"Noncoding RNAs as sensors of tumor microenvironmental stress","volume":"41","author":"Lv","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"785","key":"10.1016\/j.critrevonc.2026.105385_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adm7269","article-title":"\"Tumor extracellular vesicle\u2013derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming","volume":"17","author":"Ma","year":"2025","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","article-title":"\"CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105385_bib50","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41556-024-01465-0","article-title":"\"p16-dependent increase of PD-L1 stability regulates immunosurveillance of senescent cells","volume":"26","author":"Majewska","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105385_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17091397","article-title":"\"Influence of age on treatment and prognosis in ovarian cancer patients","volume":"17","author":"Mancebo","year":"2025","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105385_bib52","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00262-015-1750-0","article-title":"\"Age-related changes in natural killer cell repertoires: impact on NK cell function and immune surveillance","volume":"65","author":"Manser","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib53","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41698-025-01003-7","article-title":"\"Epigenetic regulators in cancer therapy and progression","volume":"9","author":"Marei","year":"2025","journal-title":"NPJ Precis Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105385_bib54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tig.2022.03.010","article-title":"\"DNA methylation: a historical perspective","volume":"38","author":"Mattei","year":"2022","journal-title":"Trends Genet."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105385_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13030545","article-title":"\"Role of methylation in pro- and anti-cancer immunity","volume":"13","author":"Mehdi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105385_bib56","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","article-title":"\"Influence of the tumor microenvironment on NK cell function in solid tumors","volume":"10","author":"Melaiu","year":"2019","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105385_bib57","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"\"The cancer-immunity cycle: Indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105385_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030420","article-title":"\"Role of p53 in the regulation of cellular senescence","volume":"10","author":"Mijit","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105385_bib59","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","article-title":"\"Hallmarks of T cell aging","volume":"22","author":"Mittelbrunn","year":"2021","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105385_bib60","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/ijc.31763","article-title":"\"Senescence markers: predictive for response to checkpoint inhibitors","volume":"144","author":"Moreira","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105385_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1353787","article-title":"\"Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy","volume":"15","author":"Nicolini","year":"2024","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105385_bib62","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122961","article-title":"\"Age-related tumor growth in mice is related to integrin \u03b1 4 in CD8+ T cells","volume":"3","author":"Oh","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-023-02846-3","article-title":"\"CD28\/PD1 co-expression: dual impact on CD8+ T cells in peripheral blood and tumor tissue, and its significance in NSCLC patients' survival and ICB response","volume":"42","author":"Palermo","year":"2023","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100336","article-title":"\"Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers","volume":"7","author":"Palmeri","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.critrevonc.2026.105385_bib65","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3389\/fimmu.2017.01124","article-title":"\"The molecular mechanism of natural killer cells function and its importance in cancer immunotherapy","volume":"8","author":"Paul","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105385_bib66","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/s41590-020-0643-3","article-title":"\"Sestrins induce natural killer function in senescent-like CD8(+) T cells.\"","volume":"21","author":"Pereira","year":"2020","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105385_bib67","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41584-022-00905-1","article-title":"\"Inflammation and DNA damage: cause, effect or both","volume":"19","author":"Pezone","year":"2023","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib68","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.31664","article-title":"\"Global cancer incidence in older adults, 2012 and 2035: a population-based study","volume":"144","author":"Pilleron","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105385_bib69","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.ccell.2023.05.006","article-title":"\"Senescent alveolar macrophages promote early-stage lung tumorigenesis","volume":"41","author":"Prieto","year":"2023","journal-title":"Cancer Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib70","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/cyto.1997.0265","article-title":"\"Generation of human lymphokine-activated killer cells following an IL-2 pulse in elderly cancer patients","volume":"10","author":"Provinciali","year":"1998","journal-title":"Cytokine"},{"key":"10.1016\/j.critrevonc.2026.105385_bib71","doi-asserted-by":"crossref","DOI":"10.14336\/AD.2025.0053","article-title":"\"NK cell senescence in cancer: from molecular mechanisms to therapeutic opportunities.\"","author":"Qiu","year":"2025","journal-title":"Aging Dis."},{"key":"10.1016\/j.critrevonc.2026.105385_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.713132","article-title":"\"Polyfunctional KLRG-1(+)CD57(+) senescent CD4(+) T cells infiltrate tumors and are expanded in peripheral blood from breast cancer patients.\"","volume":"12","author":"Ramello","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib73","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41467-022-28523-1","article-title":"\"T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10","volume":"13","author":"Ravi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.critrevonc.2026.105385_bib74","first-page":"1527","article-title":"\"Interferon-\u03b3 and celecoxib inhibit lung-tumor growth through modulating M2\/M1 macrophage ratio in the tumor microenvironment.\"","author":"Ren","year":"2014","journal-title":"Drug Des. Dev. Ther. 8"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12929-025-01146-6","article-title":"\"Meta-epigenetic shifts in T cell aging and aging-related dysfunction","volume":"32","author":"Rousseau","year":"2025","journal-title":"J. Biomed. Sci."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105385_bib76","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.cell.2005.09.044","article-title":"\"Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release","volume":"123","author":"Rubin","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105385_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1235902","article-title":"\"Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer","volume":"13","author":"Sammons","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105385_bib78","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13148-018-0512-1","article-title":"\"DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer","volume":"10","author":"Sasidharan Nair","year":"2018","journal-title":"Clin. Epigenet."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib79","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","article-title":"\"The tumor microenvironment represses t cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction","volume":"45","author":"Scharping","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.critrevonc.2026.105385_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155747","article-title":"\"The role of ROS in tumor infiltrating immune cells and cancer immunotherapy","volume":"151","author":"Shah","year":"2024","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105385_bib81","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154334","article-title":"\"Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse","volume":"132","author":"Shapiro","year":"2022","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib82","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/s41419-025-08000-5","article-title":"\"Senescent macrophages in tumor: phenotypes, roles, and interventions","volume":"16","author":"Shen","year":"2025","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105385_bib83","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","article-title":"\"The role of non-coding RNAs in oncology","volume":"179","author":"Slack","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105385_bib84","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14300","article-title":"\"Are immunosenescent T cells really senescent?\"","volume":"23","author":"Slaets","year":"2024","journal-title":"Aging Cell"},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105385_bib85","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1158\/0008-5472.CAN-19-3670","article-title":"\"Autocrine IL6-mediated activation of the STAT3-DNMT axis silences the TNF\u03b1-RIP1 necroptosis pathway to sustain survival and accumulation of myeloid-derived suppressor cells.\"","volume":"80","author":"Smith","year":"2020","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib86","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43046-025-00264-4","article-title":"\"Unlocking the therapeutic potential of antibody-drug conjugates in targeting molecular biomarkers in non-small cell lung cancer","volume":"37","author":"Soni","year":"2025","journal-title":"J. Egypt Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105385_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030558","article-title":"\"Telomeres and telomere length: a general overview","volume":"12","author":"Srinivas","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105385_bib88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.726492","article-title":"\"Multi-parameter quantitative imaging of tumor microenvironments reveals perivascular immune niches associated with anti-tumor immunity","volume":"12","author":"Stoltzfus","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105385_bib89","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"\"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41408-024-01193-6","article-title":"\"Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies","volume":"14","author":"Tao","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.critrevonc.2026.105385_bib91","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fonc.2019.01223","article-title":"\"IL-6 and IL-8 are linked with myeloid-derived suppressor cell accumulation and correlate with poor clinical outcomes in melanoma patients","volume":"9","author":"Tobin","year":"2019","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105385_bib92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.it.2021.03.006","article-title":"\"How metabolism bridles cytotoxic CD8(+) T cells through epigenetic modifications.\"","volume":"42","author":"Van Acker","year":"2021","journal-title":"Trends Immunol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105385_bib93","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-006677","article-title":"\"Tumor cell-induced macrophage senescence plays a pivotal role in tumor initiation followed by stable growth in immunocompetent condition","volume":"11","author":"Wada","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105385_bib94","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/geront\/4.4.195","article-title":"\"The immunologic theory of aging","volume":"4","author":"Walford","year":"1964","journal-title":"Gerontologist"},{"key":"10.1016\/j.critrevonc.2026.105385_bib95","article-title":"\"Thymic function associated with cancer development, relapse, and antitumor immunity \u2013 a mini-review","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105385_bib96","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010822","article-title":"\"Co-expression of IL-15 and CCL21 strengthens CAR-NK cells to eliminate tumors in concert with T cells and equips them with PI3K\/AKT\/mTOR signal signature","volume":"13","author":"Wang","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105385_bib97","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.4049\/jimmunol.178.3.1357","article-title":"\"IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo","volume":"178","author":"Watkins","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105385_bib98","doi-asserted-by":"crossref","DOI":"10.1007\/s10522-025-10273-4","article-title":"\"Mitochondrial dysfunction and aging: multidimensional mechanisms and therapeutic strategies","volume":"26","author":"Wei","year":"2025","journal-title":"Biogerontology"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105385_bib99","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.immuni.2025.07.012","article-title":"\"Mitochondria reactive oxygen species signaling-dependent immune responses in macrophages and T cells","volume":"58","author":"Weinberg","year":"2025","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"\"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105385_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2025.102783","article-title":"\"Advancing T-cell immunotherapy for cellular senescence and disease: Mechanisms, challenges, and clinical prospects","volume":"109","author":"Wu","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.critrevonc.2026.105385_bib102","doi-asserted-by":"crossref","unstructured":"Wu, L., Yan, J., Bai, Y., Chen, F., Xu, J., Zou, X., , 2021. \"Spatially-resolved transcriptomics analyses of invasive fronts in solid tumors \" bioRxiv.http:\/\/dx.doi.org\/10.1101\/2021.10.21.465135.","DOI":"10.1101\/2021.10.21.465135"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105385_bib103","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71223","article-title":"\"Cellular Senescence and Immunosenescence in melanoma: insights from the tumor microenvironment","volume":"14","author":"Xiong","year":"2025","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib104","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010403","article-title":"\"Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors","volume":"13","author":"Xu","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105385_bib105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ijc.32151","article-title":"\"IL-10 derived from M2 macrophage promotes cancer stemness via JAK1\/STAT1\/NF-\u03baB\/Notch1 pathway in non-small cell lung cancer","volume":"145","author":"Yang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105385_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103081","article-title":"\"Efficacy and safety of immune checkpoint inhibitors in elderly patients with advanced non-small cell lung cancer: a systematic review and meta-analysis","volume":"81","author":"Yao","year":"2025","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105385_bib107","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.15252\/emmm.201403918","article-title":"\"TLR8 signaling enhances tumor immunity by preventing tumor-induced T-cell senescence","volume":"6","author":"Ye","year":"2014","journal-title":"EMBO Mol. Med."},{"issue":"7779","key":"10.1016\/j.critrevonc.2026.105385_bib108","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"\"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib109","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13045-023-01492-8","article-title":"\"Challenges and new technologies in adoptive cell therapy","volume":"16","author":"Zhang","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105385_bib110","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.ccell.2022.09.013","article-title":"\"Depletion of BATF in CAR-T cells enhances antitumor activity by inducing resistance against exhaustion and formation of central memory cells","volume":"40","author":"Zhang","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.critrevonc.2026.105385_bib111","article-title":"\"Mechanisms of senescence-related NKG2D ligands release and immune escape induced by chemotherapy in neuroblastoma cells","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41416-023-02292-0","article-title":"\"Reshaping the tumour immune microenvironment in solid tumours via tumour cell and immune cell DNA methylation: from mechanisms to therapeutics","volume":"129","author":"Zhong","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jimmun\/vkae004","article-title":"\"Memory-like NK cell differentiation, inhibitory NKG2A blockade, and improved recognition via antibody or CAR engineering combine to enhance NK cell attack against multiple myeloma","volume":"214","author":"Zhou","year":"2025","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib114","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-024-01633-x","article-title":"\"The interaction between DNA methylation and tumor immune microenvironment: from the laboratory to clinical applications","volume":"16","author":"Zhu","year":"2024","journal-title":"Clin. Epigenet."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105385_bib115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.stem.2020.05.008","article-title":"\"Metabolic reprograming via deletion of cish in human iPSC-derived NK cells promotes in vivo persistence and enhances anti-tumor activity","volume":"27","author":"Zhu","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105385_bib116","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12943-024-01973-5","article-title":"\"The senescence journey in cancer immunoediting","volume":"23","author":"Zingoni","year":"2024","journal-title":"Mol. Cancer"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:17:09Z","timestamp":1783052229000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":116,"alternative-id":["S1040842826002726"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105385","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bidirectional roles of senescence in tumor-infiltrating immune cells: Mechanisms, impact on immunotherapy, and therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105385","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105385"}}